Aetna (NYSE: AET) reported Q4 EPS of $1.25, $0.05 better than the analyst estimate of $1.20. Revenue for the quarter came in at $14.74 billion versus the consensus estimate of $14.88 billion.

“Aetna’s strong 2017 results demonstrate the power and versatility of our core businesses,” said Mark T. Bertolini, Aetna chairman and CEO. “As we progress toward completing our pending transaction with CVS Health, we remain focused on serving our members and delivering on our strategic and financial objectives. We are confident that the combined entity will deliver a better health care experience by improving access to affordable health care and coordination of health services in communities across the country.”

“We closed 2017 with a strong fourth quarter performance,” said Shawn M. Guertin, Aetna executive vice president and CFO. “Continued strength within our government business and moderate medical cost trend drove our better than projected total company results in the period. This momentum, combined with our targeted investments position Aetna for another year of operational success in 2018.”

For earnings history and earnings-related data on Aetna (AET) click here.